Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th

Company Overview - Envoy Medical, Inc. is a hearing health company focused on fully implanted hearing devices that utilize the ear's natural anatomy [6] - The company has developed unique devices such as the Esteem® active middle ear implant and the investigational Acclaim® cochlear implant [6][8] Recent Developments - Brent Lucas, CEO of Envoy Medical, will present at the Life Sciences Virtual Investor Forum on June 12, 2025, allowing real-time interaction with investors [1][2] - The Acclaim CI has received Breakthrough Device Designation from the FDA in 2019 and is designed for severe to profound sensorineural hearing loss [8] Clinical Trials - Envoy Medical's pivotal clinical trial for the Acclaim CI is on track after the first month follow-up, with optimism about progressing to the final stage of the trial [9] Product Features - The Acclaim CI is a first-of-its-kind device that captures sound using the ear's natural anatomy and is powered by a rechargeable battery [7] - The Esteem FI-AMEI is the only FDA-approved fully implanted hearing device for adults with moderate to severe sensorineural hearing loss, offering continuous hearing without external components [11]